English 中文網 漫畫網 愛新聞iNews 翻譯論壇
    中國網站品牌欄目(頻道)
    當前位置: Language Tips > 每日播報

    H7N9 vaccine trials urged as new cases continue to emerge

    [ 2014-02-10 10:08] 來源:中國日報網     字號 [] [] []  
    免費訂閱30天China Daily雙語新聞手機報:移動用戶編輯短信CD至106580009009

    Download

    Clinical trials should be carried out sooner for H7N9 vaccine products, but it's not necessary to conduct large-scale public immunization, experts said.

    Researchers at the Shanghai Public Health Clinical Center have recently developed a genetic vaccine against H7N9 and are applying for it to undergo clinical trials.

    On Jan 7, Hualan Biological Engineering Inc, in Henan province, announced on its website it had finished the preclinical study of its H7N9 vaccine products and that it is waiting for the China Food and Drug Administration to approve of its application for clinical trials of the vaccine.

    But the CFDA has not yet approved clinical trials on any H7N9 vaccine products, said Shu Yuelong, director of the Chinese National Influenza Center.

    "How long it takes before we get a reply depends on where we are on the waiting list and whether the documentation we filed is fully prepared," said Liu Peicheng, an official at Sinovac Biotech Ltd in Beijing.

    The company announced on its website on Jan 29 that it had filed an application of clinical trials for its H7N9 vaccine products.

    Liu said it's possible that if H7N9 cases were to flare, the testing process would accelerate.

    In 2009, when human infections of H1N1 were frequently reported, the CFDA raised the priority of H1N1 vaccine product assessments, shortening waits for testing and streamlining their path to the market.

    "It's better that clinical trials (for H7N9 vaccine products) start sooner because it takes time to complete the testing," said Shu from the influenza center.

    A 53-year-old man in Jiangsu province was diagnosed with H7N9 on Saturday. The provincial health bureau said he transported two truckloads of chicken feathers from butchered chickens before he got sick.

    A 75-year-old woman diagnosed with H7N9 in Nanjing on Jan 30 died on Friday despite emergency treatment, the bureau said.

    However, Shu said there is no need for a large-scale immunization because the infections remain sporadic and the virus doesn't transmit effectively among humans.

    He Jianfeng, chief expert at the Guangdong province Center for Disease Control and Prevention, said it is not cost-effective to carry out a large-scale immunization right now. But he emphasized that an H7N9 vaccine could help guarantee large-scale immunization when the virus is found to be able to transmit among human effectively.

    He doesn't expect the virus to mutate so much as to make the technology to produce H7N9 vaccines ineffective.

    "As long as it remains to be H7N9, the mutation will not require much change in the technology for us to produce a vaccine against it," he said. "We'll just need a new strain of H7N9 virus to produce the vaccine with the same technology, just like we use new strains of other kinds of flu virus to produce effective vaccines every year, because the viruses, though they are the same ones, become slightly different from year to year."

    Questions:

    1. What is the name of the company that has its preclinical study of the H7N9 vaccine?

    2. Who is the director of the Chinese National Influenza Center?

    3. Where does He Jianfeng work?

    Answers:

    1. Hualan Biological Engineering Inc.

    2. Shu Yuelong.

    3. Center for Disease Control and Prevention in Guangdong province.

    (中國日報網英語點津 Helen 編輯)

    H7N9 vaccine trials urged as new cases continue to emerge

    About the broadcaster:

    H7N9 vaccine trials urged as new cases continue to emerge

    Lance Crayon is a videographer and editor with China Daily. Since living in Beijing he has worked for China Radio International (CRI) and Global Times. Before moving to China he worked in the film industry in Los Angeles as a talent agent and producer. He has a B.A. in English from the University of Texas at Arlington.

     
    中國日報網英語點津版權說明:凡注明來源為“中國日報網英語點津:XXX(署名)”的原創作品,除與中國日報網簽署英語點津內容授權協議的網站外,其他任何網站或單位未經允許不得非法盜鏈、轉載和使用,違者必究。如需使用,請與010-84883631聯系;凡本網注明“來源:XXX(非英語點津)”的作品,均轉載自其它媒體,目的在于傳播更多信息,其他媒體如需轉載,請與稿件來源方聯系,如產生任何問題與本網無關;本網所發布的歌曲、電影片段,版權歸原作者所有,僅供學習與研究,如果侵權,請提供版權證明,以便盡快刪除。
     

    關注和訂閱

    人氣排行

    翻譯服務

    中國日報網翻譯工作室

    我們提供:媒體、文化、財經法律等專業領域的中英互譯服務
    電話:010-84883468
    郵件:translate@chinadaily.com.cn
     
     
    国产精品亚洲αv天堂无码 | 亚洲国产AV无码专区亚洲AV| 最近免费视频中文字幕大全 | 亚洲av无码成人精品国产| 久久午夜无码鲁丝片午夜精品 | 亚洲中文字幕无码爆乳av中文 | 日韩精品中文字幕第2页| 亚洲中文字幕不卡无码| 久久久无码精品亚洲日韩按摩 | 亚洲AV无码成人网站久久精品大| 无码中文人妻视频2019| 无码人妻少妇久久中文字幕| 一二三四社区在线中文视频| 自拍中文精品无码| 欧美人妻aⅴ中文字幕| 寂寞少妇做spa按摩无码| 精品人体无码一区二区三区| 无码一区二区三区视频| 无码成人精品区在线观看| 免费无码国产V片在线观看| 午夜亚洲AV日韩AV无码大全 | 无码AV动漫精品一区二区免费| 日韩亚洲欧美中文在线| 久久亚洲精品成人无码网站| 国产精品亚洲w码日韩中文| 亚洲精品无码永久中文字幕| 天天爽亚洲中文字幕| 五十路熟妇高熟无码视频| 亚洲AV无码一区二区三区在线观看 | 无码色AV一二区在线播放| 精选观看中文字幕高清无码| 18禁黄无码高潮喷水乱伦| 日本无码WWW在线视频观看| 久久久网中文字幕| 日本中文字幕在线电影| 久久无码中文字幕东京热| 中文字幕av无码专区第一页| 亚洲av永久无码精品漫画| 亚洲av无码一区二区三区四区 | 一本一道av中文字幕无码| 亚洲AV无码成人专区片在线观看|